The Procter & Gamble Company

NYSE:PG

Household & Personal Products

Consumer Defensive
$170.29 +0.35%

+$0.53 today

Market cap
$394.70B
Beta
0.39
P/E (TTM)
21.9
EPS (TTM)
$6.90
Dividend yield
2.82%
52W Low $137.62High $167.25

Volume 8.43M

Average 9.50M

PG Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

The Procter & Gamble CompanyNYSE: PG

Research & Development · Q1 FY2027 · quarter ended Sep 2026

Research & development remains negative

Q1 FY2027 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

Context

  • Research & development amounted to 0.0% of revenue in FY2026, unchanged from a year earlier.
  • Research & development increased in 0 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$0— QoQ
Last fiscal yearJun 2026
$0— YoY
LTMSep 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2026
0 USD
Year-over-year change
—

Research & Development vs competitors

How PG compares with its peers on the latest reported figures

  • Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
  • Research & development amounts to 0.0% of revenue for PG, versus a peer median of 0.0%.
PG Competitors
Research & Development for PG and competitors
Company Period LTM YoY 3-year CAGR% of revenue
KVUEKenvue Inc.LTM Sep 2026$180M USD——1.2%
CLXThe Clorox CompanyLTM Sep 2026$117M USD-0.8%-5.6%1.6%
PGThe Procter & Gamble CompanyLTM Sep 2026$0 USD——0.0%
ULUnilever PLCFY2025€0 EUR——0.0%
CLColgate-Palmolive CompanyLTM Sep 2026$0 USD-100.0%+4.6%0.0%
ELThe Estée Lauder Companies Inc.LTM Sep 2026$0 USD——0.0%
KMBKimberly-Clark CorporationLTM Jun 2026$0 USD-100.0%—0.0%
CHDChurch & Dwight Co., Inc.LTM Sep 2026$0 USD——0.0%
Peer median (excluding PG) —-100.0%-0.5%0.0%

Competitors are the stored peer set for PG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
FY2026
Jun 2026
Revenue80.19B82.01B84.04B84.28B87.03B
Cost of Revenue42.16B42.76B40.85B41.16B43.36B
Gross Profit38.03B39.25B43.19B43.12B43.67B
Gross Margin47.4%47.9%51.4%51.2%50.2%
Research & Development00000
Selling, General & Admin20.22B21.11B23.31B22.67B23.92B
Operating Expenses20.22B21.11B24.65B22.67B23.92B
Depreciation & Amortization2.81B2.71B2.9B2.85B3.16B
EBITDA21.24B21.77B22.58B23.92B24.41B
EBITDA Margin26.5%26.5%26.9%28.4%28.1%
Operating Income17.81B18.13B18.55B20.45B19.75B
Operating Margin22.2%22.1%22.1%24.3%22.7%
Interest Income51M307M473M469M430M
Interest Expense439M756M925M907M877M
Other Income / Expenses182M219M216M(284M)629M
Income Before Tax18B18.35B18.76B20.17B20.38B
Pre-Tax Margin22.4%22.4%22.3%23.9%23.4%
Income Tax Expense3.2B3.62B3.79B4.1B4.23B
Net Income14.74B14.65B14.88B15.97B16.05B
Net Margin18.4%17.9%17.7%19.0%18.4%
EPS (Basic)6.006.076.186.676.75
EPS (Diluted)5.815.906.026.516.62
Weighted Avg Shares2.46B2.37B2.36B2.45B2.42B
Weighted Avg Shares (Diluted)2.54B2.48B2.47B2.45B2.42B

The Procter & Gamble Company

NYSE:PG

Intrinsic Alpha fair value

Locked

Current Price

$170.29

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.